Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyProtocol groupTransplantationDiseaseHodgkin LymphomaMantle Cell LymphomaNHL, B-Cell Type, Anaplastic Large Cell Lymphoma, ALK-PositiveNHL, B-Cell Type, Diffuse Large CellNHL, B-Cell Type, Follicular Grade I-IIIaNHL, B-Cell Type, Follicular grade IIIbStem Cell Transplantation, AutologousSubgroupICD10C81.-C82.-C82.7C82.9C83.1C83.3C84.6Z94.80MeSHHodgkin DiseaseLymphoma, FollicularLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellTransplantation, AutologousSequenceChemotherapyChemo-substanceBendamustineCarmustineCytarabineEtoposideMelphalanThiotepaChemo-substanceBendamustineCarmustineCytarabineEtoposideMelphalanThiotepaChemo-substanceBendamustineCarmustineCytarabineEtoposideMelphalanThiotepaChemo-substanceBendamustineCarmustineCytarabineEtoposideMelphalanThiotepaNo. Substances4 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronNo. Substances4Protocol classificationTherapy classificationalternativecurrent standardIntensityHigh dose myeloablativeTherapy indicationRelapse therapyseveral possibleTherapy phaseconditioningTherapy intentioncurativeRisksDiarrheaEmetogenicity (MASCC/ESMO)Gastrointestinal ToxicityHepatotoxicityInfectionsMucositisOral MucositisPyrexia only studiesPublicationAuthorCaballero MDLadetto MVisani GDiseaseFollikuläres Lymphom °I-IIIa, ECOG 0-2NHL, HL, Rezidiv, fehlende Remission nach kurativer Chemotherapierefraktäres oder rezidivierendes NHL oder HL, Rituximab VortherapieOriginDepartment of Hematology, Hospital Universitario Salamanca, SpanienDepartment of Translational Medicine, University of Eastern Piedmont, Novara, Italy; FLAZ-12Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Pesaro, ItalyProtocols in Revision 3 protocols foundProtocols under revision.BEAM - Carmustine 300 / Etoposide 200 / Cytarabine 200 / Melphalan 140, prior to autologous Stem Cell Transplantation, Autologous (PID280 V2.1)BeEAM - Bendamustine 100 / Etoposide 200 / Cytarabine 200 / Melphalan 140, prior to autologous Stem Cell Transplantation (PID879 V1.0)TEAM - Thiotepa 5 / Etoposide 200 / Cytarabine 200 / Melphalan 140, prior to Stem Cell Transplantation, Autologous (PID406 V2.0)
